Notificação de entrada na fase nacional - PCT
#1.3
03/07/2023
RPI 2722
Application data
Number
112023002134Type
Filing
Publication
PCT
US2021044318 The application was filed at the INPI on 08/03/2021. It awaits formal examination and publication in the RPI gazette.
Latest action published by the INPI: 03/07/2023. We update with every new RPI gazette, published weekly.
Applicants
CONSTELLATION PHARMACEUTICALS, INC.
US
Inventors
A. S. (pessoa física)
US
IPC Classification
Priority claims
US
63/060,723 · 08/04/2020
Abstract
2-((4S)-6-(4-CLOROFENIL)-1-METIL-4H-BENZO[C]ISOXAZOLO[4,5-E]AZEPIN-4-IL)ACETAMIDA PARA TRATAMENTO DE TROMBOCITEMIA. A presente invenção refere-se ao uso de 2-((4S)-6-(4-clorofenil)-l-metil -4 H-benzo [c] isoxazolo [4,5-e] azepin-4-il) acetamida, e seus sais farmaceuticamente aceitáveis, para o tratamento de trombocitemia.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
03/07/2023
RPI 2722
#1.1
02/14/2023
RPI 2719
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.